Last reviewed · How we verify
Lactobacillus Rhamnosus GG
At a glance
| Generic name | Lactobacillus Rhamnosus GG |
|---|---|
| Also known as | Prepro GG, Culturelle |
| Sponsor | Madiha, MPhil |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Probiotic (LGG) for Veterans With PTSD (PHASE2)
- The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee (NA)
- GynMDD Add-On to Supportive Psychotherapy in Mild to Moderate Depression (NA)
- Evaluating the LGG of on Acute Infectious Diarrhea in Children (NA)
- Probiotics for Autism Spectrum Disorders: a Randomized Controlled Trial (The PASD Study) (NA)
- A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis (NA)
- Single Vs Multi-strain Probiotics for Preterm Neonates (PHASE4)
- A Probiotic Intervention to Prevent Relapse Following Hospitalization for Mania (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lactobacillus Rhamnosus GG CI brief — competitive landscape report
- Lactobacillus Rhamnosus GG updates RSS · CI watch RSS
- Madiha, MPhil portfolio CI